Bristol-Myers Immunotherapy Drug Impresses With Phase 2 Lung Cancer Data By: TalkMarkets October 30, 2014 at 21:22 PM EDT Bristol-Myers posts outstanding results In lung cancer data using immunotherapy drug Read More >> Related Stocks: Bristol-Myers Squibb